BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1145@pharmaconomics
DTSTAMP:20260707T015748Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:GSK Approval — bepirovirsen (estimated date)
DESCRIPTION:A final FDA approval decision on bepirovirsen for chronic hepatitis B is expected ~ Mar 27\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1131399/000165495426001578/a4533u.htm\n\nTrack it: https://pharmaconomics.com/e/1145
URL:https://pharmaconomics.com/e/1145
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:GSK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR